Jesper Hallas

Medicin og biovidenskab

1. Denmark 100%
2. Prescriptions 84%
3. Pharmaceutical Preparations 67%
4. Case-Control Studies 67%
5. Cohort Studies 60%
6. Confidence Intervals 53%
7. Registries 48%
8. Population 48%
9. Odds Ratio 48%
10. Hydroxymethylglutaryl-CoA Reductase Inhibitors 35%
11. Mortality 33%
12. Drug Utilization 29%
13. Databases 26%
14. Vitamin K 26%
15. Hemorrhage 25%
16. Anticoagulants 25%
17. Anti-Inflammatory Agents 23%
18. Prescription Drugs 21%
19. Therapeutics 21%
20. Aspirin 20%
21. Atrial Fibrillation 18%
22. Propensity Score 17%
23. Stroke 17%
24. Incidence 17%
25. Proton Pump Inhibitors 17%
26. Chronic Obstructive Pulmonary Disease 16%
27. phthalic acid 16%
28. Serotonin Uptake Inhibitors 16%
29. Comorbidity 15%
30. Antidepressive Agents 15%
31. Muscarinic Antagonists 15%
32. Peptic Ulcer 14%
33. Overactive Urinary Bladder 13%
34. Neoplasms 13%
35. Myocardial Infarction 13%
36. Delivery of Health Care 12%
37. Pharmacists 12%
38. Information Storage and Retrieval 12%
39. Randomized Controlled Trials 12%
40. Logistic Models 12%
41. SARS Virus 12%
42. Sweden 12%
43. Warfarin 12%
44. Helicobacter pylori 11%
45. Hospital Formularies 11%
46. Non-Steroidal Anti-Inflammatory Agents 11%
47. Observational Studies 11%
48. Anti-Bacterial Agents 11%
49. Angiotensin Receptor Antagonists 11%
50. Adrenal Cortex Hormones 10%